Mga Batayang Estadistika
| CIK | 927761 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Mymetics Corporation
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| January 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 000-25132 Mymetics Corporation (Exact name of registrant as specified in it |
|
| December 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 28, 2023 MYMETICS CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 000-25132 25-1741849 (State or other jurisdiction of incorporation) (Commission |
|
| December 28, 2023 |
EXHIBIT 3.1 CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MYMETICS CORPORATION Mymetics Corporation (the “Corporation”), a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the “General Corporation Law”), DOES HEREBY CERTIFY: 1. The Corporation’s Amended and Restated Certificate of In |
|
| December 8, 2023 |
As filed with the Securities and Exchange Commission on December 8, 2023. As filed with the Securities and Exchange Commission on December 8, 2023. Registration No. 333-15829 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to Form S-8 Registration Statement UNDER THE SECURITIES ACT OF 1933 MYMETICS CORPORATION (Exact name of registrant as specified in its charter) Delaware /o Mymetics SA Route de la Corniche 4 1066 |
|
| December 8, 2023 |
As filed with the Securities and Exchange Commission on December 8, 2023. As filed with the Securities and Exchange Commission on December 8, 2023. Registration No. 333-88782 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MYMETICS CORPORATION (Exact name of registrant as specified in its charter) Delaware 2836 25-1741849 (State or other jurisdictio |
|
| December 8, 2023 |
As filed with the Securities and Exchange Commission on December 8, 2023. As filed with the Securities and Exchange Commission on December 8, 2023. Registration No. 333-195215 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to Form S-8 Registration Statement UNDER THE SECURITIES ACT OF 1933 MYMETICS CORPORATION (Exact name of registrant as specified in its charter) Delaware /o Mymetics SA Route de la Corniche 4 1066 |
|
| December 8, 2023 |
As filed with the Securities and Exchange Commission on December 8, 2023. As filed with the Securities and Exchange Commission on December 8, 2023. Registration No. 333-15831 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to Form S-8 Registration Statement UNDER THE SECURITIES ACT OF 1933 MYMETICS CORPORATION (Exact name of registrant as specified in its charter) Delaware /o Mymetics SA Route de la Corniche 4 1066 |
|
| November 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25132 MYMETICS CORPORA |
|
| November 15, 2023 |
OMB APPROVAL OMB Number: 3235-0058 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| October 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13E–3/A (Rule 13e–100) (Amendment No. 1) RULE 13E–3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 MYMETICS CORPORATION (Name of the Issuer) Mymetics Corporation Ronald Kempers Thomas Staehelin Ulrich Burkhard Marcel B. Rüegg Round Enterprises Ltd. Eardley Holding AG (Name of Person(s |
|
| October 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☒ Definitive Information Statement MYMETICS CORPORATION (Name of Regist |
|
| October 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2023 Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of incorporation) (Commission F |
|
| October 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13E–3 (Rule 13e–100) RULE 13E–3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 MYMETICS CORPORATION (Name of the Issuer) Mymetics Corporation Ronald Kempers Thomas Staehelin Ulrich Burkhard Marcel B. Rüegg Round Enterprises Ltd. Eardley Holding AG (Name of Person(s) Filing Statement) |
|
| October 17, 2023 |
Exhibit 107 Calculation of Filing Fee Tables Schedule 13E-3 (Form Type) Mymetics Corporation (Name of the Issuer and Name of Person Filing Statement) Table 1 – Transaction Value Transaction Valuation Fee Rate Amount of Filing Fee Fees to Be Paid $ 1,937 (1) $ 0. |
|
| October 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement MYMETICS CORPORATION (Name of Regist |
|
| October 11, 2023 |
Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 11, 2023 Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction (Commission (IRS Employer of in |
|
| August 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25132 MYMETICS CORPORATION |
|
| August 15, 2023 |
OMB APPROVAL OMB Number: 3235-0058 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| July 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2023 Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction (Commission (IRS Employer of incor |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25132 MYMETICS CORPORATION |
|
| April 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 000-25132 MYMETICS CORPORATION (Exac |
|
| April 11, 2023 |
EXHIBIT 21.1 SUBSIDIARIES Mymetics Corporation has three subsidiaries: 1. Mymetics S.A. (a wholly-owned subsidiary of Mymetics Corporation) is a company organized under the laws of Switzerland and did business under the names “Mymetics S.A.” during 2022. 2. Bestewil Holding B.V. (a wholly-owned subsidiary of Mymetics Corporation) is a company organized under the laws of the Netherlands and did bus |
|
| April 11, 2023 |
EXHIBIT 14.1 CODE OF ETHICS The Chief Executive Officer ("CEO") and all senior financial officers, including the Chief Financial Officer and principal accounting officer of Mymetics Corporation (the "Company"), and of any subsidiary that becomes subject to the periodic reporting requirements under Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended, are bound by the p |
|
| April 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response.......2.50 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-25132 CUSIP NUMBER 693286-10-6 (Check one): ☑ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: Decemb |
|
| February 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2023 Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of incorporation) (Commission |
|
| February 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2023 Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of incorporation) (Commission F |
|
| January 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 16, 2023 Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of incorporation) (Commission F |
|
| December 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2022 Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of incorporation) (Commission |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25132 MYMETICS CORPORA |
|
| August 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25132 MYMETICS CORPORATION |
|
| May 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25132 MYMETICS CORPORATION |
|
| April 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A Amendment No. 1 ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 000-25132 MYMETICS |
|
| April 4, 2022 |
Exhibit 21.1 SUBSIDIARIES Mymetics Corporation has three subsidiaries: 1. Mymetics S.A. (a wholly-owned subsidiary of Mymetics Corporation) is a company organized under the laws of Switzerland and did business under the names ?Mymetics S.A.? during 2021. 2. Bestewil Holding B.V. (a wholly-owned subsidiary of Mymetics Corporation) is a company organized under the laws of the Netherlands and did bus |
|
| April 4, 2022 |
Exhibit 14.1 CODE OF ETHICS The Chief Executive Officer ("CEO") and all senior financial officers, including the Chief Financial Officer and principal accounting officer of Mymetics Corporation (the "Company"), and of any subsidiary that becomes subject to the periodic reporting requirements under Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended, are bound by the p |
|
| March 31, 2022 |
Exhibit 21.1 SUBSIDIARIES Mymetics Corporation has three subsidiaries: 1. Mymetics S.A. (a wholly-owned subsidiary of Mymetics Corporation) is a company organized under the laws of Switzerland and did business under the names ?Mymetics S.A.? during 2021. 2. Bestewil Holding B.V. (a wholly-owned subsidiary of Mymetics Corporation) is a company organized under the laws of the Netherlands and did bus |
|
| March 31, 2022 |
Exhibit 14.1 CODE OF ETHICS The Chief Executive Officer ("CEO") and all senior financial officers, including the Chief Financial Officer and principal accounting officer of Mymetics Corporation (the "Company"), and of any subsidiary that becomes subject to the periodic reporting requirements under Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended, are bound by the p |
|
| March 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 000-25132 MYMETICS CORPORATION (Exac |
|
| November 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25132 MYMETICS CORPORA |
|
| August 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25132 MYMETICS CORPORATION |
|
| August 16, 2021 |
Changes in Registrant’s Certifying Accountant EXHIBIT 16.1 Changes in Registrant?s Certifying Accountant On June 15, 2021, the registrant (?Mymetics? or the ?Company?), through and with the approval of its Audit Committee, appointed Fruci & Associates II, PLLC (?Fruci & Associates?) to replace BDO USA, LLP ("BDO") as its independent registered public accounting firm following BDO informing the Company that BDO had increased its fees to audit |
|
| June 17, 2021 |
Exhibit 16.1 June 17, 2021 Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 We have been furnished with a copy of the response to Item 4.01 of Form 8-K for the event that occurred on June 15, 2021, to be filed by our former client, Mymetics Corporation. We agree with the statements made in response to that Item insofar as they relate to our Firm. Very truly yours, /s/ BD |
|
| June 17, 2021 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 17, 2021 Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of incorporation) (Commission File |
|
| May 18, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25132 MYMETICS CORPORATION |
|
| May 18, 2021 |
OMB APPROVAL OMB Number: 3235-0058 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 31, 2021 |
Exhibit 14.1 CODE OF ETHICS The Chief Executive Officer ("CEO") and all senior financial officers, including the Chief Financial Officer and principal accounting officer of Mymetics Corporation (the "Company"), and of any subsidiary that becomes subject to the periodic reporting requirements under Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended, are bound by the p |
|
| March 31, 2021 |
Exhibit 21.1 SUBSIDIARIES Mymetics Corporation has three subsidiaries: 1. Mymetics S.A. (a wholly-owned subsidiary of Mymetics Corporation) is a company organized under the laws of Switzerland and did business under the names ?Mymetics S.A.? during 2020. 2. Bestewil Holding B.V. (a wholly-owned subsidiary of Mymetics Corporation) is a company organized under the laws of the Netherlands and did bus |
|
| March 31, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 00025132 MYMETICS CORPORATION (Exact |
|
| March 23, 2021 |
Quarterly Report - FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 1) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25 |
|
| November 13, 2020 |
Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25132 MYMETICS CORPORA |
|
| August 13, 2020 |
Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25132 MYMETICS CORPORATION |
|
| May 15, 2020 |
Quarterly Report - QUARTELY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25132 MYMETICS CORPORATION |
|
| March 30, 2020 |
MYMX / Mymetics Corp. 10-K - Annual Report - ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 00025132 MYMETICS CORPORATION (Exact |
|
| March 30, 2020 |
Exhibit 14.1 CODE OF ETHICS The Chief Executive Officer ("CEO") and all senior financial officers, including the Chief Financial Officer and principal accounting officer of Mymetics Corporation (the "Company"), and of any subsidiary that becomes subject to the periodic reporting requirements under Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended, are bound by the p |
|
| March 30, 2020 |
Exhibit 21.1 SUBSIDIARIES Mymetics Corporation has three subsidiaries: 1. Mymetics S.A. (a wholly-owned subsidiary of Mymetics Corporation) is a company organized under the laws of Switzerland and did business under the names “Mymetics S.A.” during 2019. 2. Bestewil Holding B.V. (a wholly-owned subsidiary of Mymetics Corporation) is a company organized under the laws of the Netherlands and did bus |
|
| January 7, 2020 |
MYMX / Mymetics Corp. DEF 14C - - DEFINITIVE INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C AMENDMENT NO. 1 Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, For Use of the Commission Only (As Permitted by Rule 14c-5(d)( |
|
| January 7, 2020 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 7, 2020 Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of incorporation) (Commission Fi |
|
| January 7, 2020 |
Exhibit 16.1 |
|
| January 3, 2020 |
MYMX / Mymetics Corp. CORRESP - - MYMETICS CORPORATION Route de la Corniche 4 1066 Epalinges, Switzerland January 3, 2020 Via Edgar Correspondence Chris Edwards Office of Life Sciences Division of Corporation Finance Securities and Exchange Commission 100 F Street, N. |
|
| January 3, 2020 |
MYMX / Mymetics Corp. PRER14C - - AMENDED PRELIMINARY INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C AMENDMENT NO. 1 Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☑ Preliminary Information Statement ☐ Confidential, For Use of the Commission Only (As Permitted by Rule 14c-5(d)( |
|
| December 27, 2019 |
MYMX / Mymetics Corp. PRE 14C - - PRELIMINARY INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☑ Preliminary Information Statement ☐ Confidential, For Use of the Commission Only (As Permitted by Rule 14c-5(d)(2)) ☐ Definitive |
|
| November 12, 2019 |
MYMX / Mymetics Corp. 10-Q - Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25132 MYMETICS CORPORA |
|
| August 13, 2019 |
MYMX / Mymetics Corp. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25132 MYMETICS CORPORATION |
|
| May 15, 2019 |
MYMX / Mymetics Corp. 10-Q Quarterly Report QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25132 MYMETICS CORPORATION |
|
| March 28, 2019 |
Exhibit 21.1 SUBSIDIARIES Mymetics Corporation has three subsidiaries: 1. Mymetics S.A. (a wholly-owned subsidiary of Mymetics Corporation) is a company organized under the laws of Switzerland and did business under the names “Mymetics S.A.” during 2018. 2. Bestewil Holding B.V. (a wholly-owned subsidiary of Mymetics Corporation) is a company organized under the laws of the Netherlands and did bus |
|
| March 28, 2019 |
Exhibit 14.1 CODE OF ETHICS The Chief Executive Officer ("CEO") and all senior financial officers, including the Chief Financial Officer and principal accounting officer of Mymetics Corporation (the "Company"), and of any subsidiary that becomes subject to the periodic reporting requirements under Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended, are bound by the p |
|
| March 28, 2019 |
MYMX / Mymetics Corp. ANNUAL REPORT (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 00025132 MYMETICS CORPORATION (Exact |
|
| November 13, 2018 |
MYMX / Mymetics Corp. QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25132 MYMETICS CORPORA |
|
| August 13, 2018 |
MYMX / Mymetics Corp. QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25132 MYMETICS CORPORATION |
|
| May 14, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25132 MYMETICS CORPORATION |
|
| April 23, 2018 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2018 (April 16, 2018) Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of incorporation |
|
| April 23, 2018 |
Exhibit 99.1 Press Release Anergis and Mymetics Start Research Collaboration Project on the use of Virosomes for Ultra-Fast Allergy Immunotherapy Epalinges, Switzerland, April 23, 2018 – Mymetics Corporation (OTCQB:MYMX), a pioneer and leader in the research and development of virosome-based vaccines, and Anergis SA, a company developing Contiguous Overlapping Peptides (COPs) for ultra-fast allerg |
|
| March 29, 2018 |
Exhibit 21.1 SUBSIDIARIES Mymetics Corporation has three subsidiaries: 1. Mymetics S.A. (a wholly-owned subsidiary of Mymetics Corporation) is a company organized under the laws of Switzerland and did business under the names “Mymetics S.A.” during 2017. 2. Bestewil Holding B.V. (a wholly-owned subsidiary of Mymetics Corporation) is a company organized under the laws of the Netherlands and did bus |
|
| March 29, 2018 |
MYMX / Mymetics Corp. ANNUAL REPORT (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 00025132 MYMETICS CORPORATION (Exact |
|
| March 29, 2018 |
Exhibit 14.1 CODE OF ETHICS The Chief Executive Officer ("CEO") and all senior financial officers, including the Chief Financial Officer and principal accounting officer of Mymetics Corporation (the "Company"), and of any subsidiary that becomes subject to the periodic reporting requirements under Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended, are bound by the p |
|
| November 13, 2017 |
MYMX / Mymetics Corp. QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25132 MYMETICS CORPORA |
|
| August 10, 2017 |
MYMX / Mymetics Corp. QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25132 MYMETICS CORPORATION |
|
| May 18, 2017 |
Mymetics AMENDED QUARTERLY REPORT (Quarterly Report) Blueprint UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25132 MYMETICS |
|
| May 11, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-25132 MYMETICS CORPORATION |
|
| March 30, 2017 |
EX-21 3 mymxex21.htm SUBSIDIARIES OF THE REGISTRANT Exhibit 21.1 SUBSIDIARIES Mymetics Corporation has three subsidiaries: 1. Mymetics S.A. (a wholly-owned subsidiary of Mymetics Corporation) is a company organized under the laws of Switzerland and did business under the names “Mymetics S.A.” during 2016. 2. Bestewil Holding B.V. (a wholly-owned subsidiary of Mymetics Corporation) is a company org |
|
| March 30, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2016 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 000-25132 MYMETICS CORPORATION (Exact n |
|
| March 30, 2017 |
EX-14.1 2 mymxex141.htm CODE OF ETHICS Exhibit 14.1 CODE OF ETHICS The Chief Executive Officer ("CEO") and all senior financial officers, including the Chief Financial Officer and principal accounting officer of Mymetics Corporation (the "Company"), and of any subsidiary that becomes subject to the periodic reporting requirements under Section 13(a) or Section 15(d) of the Securities Exchange Act |
|
| January 26, 2017 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits Blueprint UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2016 (November 29, 2016) Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of ot |
|
| January 26, 2017 |
CONFIDENTIAL DISCLOSURE AGREEMENT Blueprint Exhibit 10.1 CONFIDENTIAL DISCLOSURE AGREEMENT This Confidential Disclosure Agreement ("Agreement") dated this 1st day of April, 2014, (the "Effective Date") is entered into by and between Sanofi Pasteur Biologics, LLC, a Delaware limited liability company having a principal place of business at 38 Sidney Street, Cambridge, Massachusetts 02139 and its Affiliates who agree to be bound by |
|
| December 1, 2016 |
Blueprint Exhibit 10.1 RESEARCH AGREEMENT This Agreement is made effective as of the 21st day of October 2016 ("Effective Date") BETWEEN: Sanofi Pasteur Biologics, LLC, a Delaware limited liability corporation having a principal place of business at 38 Sidney St., Cambridge, MA 02139, USA ( together with its Affiliates "Sanofi Pasteur") and Mymetics BV, a company incorporated under the laws of the |
|
| December 1, 2016 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits Blueprint UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 1, 2016 (November 29, 2016) Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction o |
|
| November 14, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MYMETICS CORPORA |
|
| August 12, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2016 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MYMETICS CORPORATION |
|
| May 12, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2016 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MYMETICS CORPORATION |
|
| March 23, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2015 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 000-25132 MYMETICS CORPORATION (Exact n |
|
| March 23, 2016 |
Exhibit 21.1 SUBSIDIARIES Mymetics Corporation has three subsidiaries: 1. Mymetics S.A. (a wholly-owned subsidiary of Mymetics Corporation) is a company organized under the laws of Switzerland and did business under the names ?Mymetics S.A.? during 2015. 2. Bestewil Holding B.V. (a wholly-owned subsidiary of Mymetics Corporation) is a company organized under the laws of the Netherlands and did bus |
|
| March 23, 2016 |
EX-14.1 2 mymxex141.htm CODE OF ETHICS Exhibit 14.1 CODE OF ETHICS The Chief Executive Officer ("CEO") and all senior financial officers, including the Chief Financial Officer and principal accounting officer of Mymetics Corporation (the "Company"), and of any subsidiary that becomes subject to the periodic reporting requirements under Section 13(a) or Section 15(d) of the Securities Exchange Act |
|
| January 29, 2016 |
mymxex991.htm Exhibit 99.1 January 29, 2016 - Press Release Mymetics-announces discontinuation of the RSV collaborative project ? Development of virosome based vaccines on-going for HIV, Malaria and for intra-nasal flu ? New vaccine development planned for Chikungunya and Zika Epalinges, Switzerland, January 29 2016 ? Mymetics Corporation (OTCQB: MYMX), a pioneer and leader in the research and dev |
|
| January 29, 2016 |
Termination of a Material Definitive Agreement, Financial Statements and Exhibits mymx8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 29, 2016 (January 25, 2016) Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdictionof |
|
| November 13, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MYMETICS CORPORA |
|
| November 9, 2015 |
Mymetics INFORMATION STATEMENT mymxdef14c.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Information Statement o Confidential, For Use of the Commission Only (As Permitted by Rule 14c-5(d)(2 |
|
| October 26, 2015 |
Mymetics INFORMATION STATEMENT mymxpre14c.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: ? Preliminary Information Statement o Confidential, For Use of the Commission Only (As Permitted by Rul |
|
| August 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MYMETICS CORPORATION |
|
| June 24, 2015 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits mymx8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 24, 2015 (June 19, 2015) Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of inco |
|
| June 24, 2015 |
AGREEMENT BETWEEN MYMETICS S.A. AND BRESLIN AG EX-10 2 mymxex101.htm FORM 10.1 *** Text Omitted and Filed Separately Pursuant to a Confidential Treatment Request under 17 C.F.R. §§ 200.80(b)(4) and 240.24b-2(b)(1) AGREEMENT BETWEEN MYMETICS S.A. AND BRESLIN AG MYMETICS S.A. (“MYMETICS”), Route de la Corniche 4, 1066 Epalinges, Switzerland, intends to engage BRESLIN AG (“BRESLIN”), Stauffacherstrasse 45, 8004 Zurich, Switzerland and Am Pfarrhof |
|
| May 13, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MYMETICS CORPORATION |
|
| March 30, 2015 |
EX-21.1 3 mymxex211.htm SUBSIDIARIES Exhibit 21.1 SUBSIDIARIES Mymetics Corporation has three subsidiaries: 1. Mymetics S.A. (a wholly-owned subsidiary of Mymetics Corporation) is a company organized under the laws of Switzerland and did business under the names “Mymetics S.A.” during 2014. 2. Bestewil Holding B.V. (a wholly-owned subsidiary of Mymetics Corporation) is a company organized under th |
|
| March 30, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2014 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 000-25132 MYMETICS CORPORATION (Exact n |
|
| March 30, 2015 |
EX-14.1 2 mymxex141.htm CODE OF ETHICS Exhibit 14.1 CODE OF ETHICS The Chief Executive Officer ("CEO") and all senior financial officers, including the Chief Financial Officer and principal accounting officer of Mymetics Corporation (the "Company"), and of any subsidiary that becomes subject to the periodic reporting requirements under Section 13(a) or Section 15(d) of the Securities Exchange Act |
|
| March 17, 2015 |
MYMX / Mymetics Corp. / Round Enterprises, Ltd. Activist Investment Securities and Exchange Commission Washington, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2) MYMETICS CORPORATION (Name of Issuer) Common Stock (Title of Class of Securities) 693286 10 6 (CUSIP Number) Oliver Norman Round Enterprises, Ltd. Sir William Place, St. Peter Port Guernsey, GYI 4HQ Channel Islands Tel. No.: 44 (0) 1481 7 23573 Copy to: Ernest Stern, E |
|
| November 13, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER: 000-25132 MYMETICS CORPORA |
|
| September 30, 2014 |
Exhibit 99.1 Press Release: September 29, 2014 Mymetics’ promising HIV vaccine candidate obtains funding to begin study at Texas Biomedical Research Institute Epalinges, Switzerland, 29 September 2014 – Mymetics Corporation (OTCQB: MYMX), a pioneer in the research and development of virosome-based vaccines to prevent transmission of human infectious diseases across mucosal membranes, announced tod |
|
| September 30, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2014 (September 26, 2014) Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of incor |
|
| August 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MYMETICS CORPORATION |
|
| July 16, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 16, 2014 (July 14, 2014) Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of incorporation) |
|
| July 16, 2014 |
Mymetics Signs Agreement to Manufacture Virosome based HER-Vaxx Cancer Immunotherapy Exhibit 99.1 Press release Mymetics Signs Agreement to Manufacture Virosome based HER-Vaxx Cancer Immunotherapy Epalinges, Switzerland, July 16, 2014 – Mymetics (OTC BB: MYMX) announced today that it has signed an exclusive agreement with Imugene (ASX; IMU), an Australian based biopharmaceutical company, to manufacture and develop its cancer immunotherapy HER-Vaxx, which is planned to enter into a |
|
| July 16, 2014 |
Exhibit 10.1 *** Text Omitted and Filed Separately Pursuant to a Confidential Treatment Request under 17 C.F.R. §§ 200.80(b)(4) and 240.24b-2(b)(1) MASTER SERVICES AGREEMENT This Master Services Agreement (“Agreement”) is made and entered into as of 14 July, 2014 (the “Effective Date”) by and between Mymetics SA, a company organized under the laws of Switzerland, with a registered address at Route |
|
| May 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MYMETICS CORPORATION |
|
| April 11, 2014 |
MYMETICS CORPORATION 2013 STOCK INCENTIVE PLAN Exhibit 4.2 MYMETICS CORPORATION 2013 STOCK INCENTIVE PLAN 1. Establishment, Purpose and Types of Awards Mymetics Corporation, a Delaware corporation (the “Company”), hereby establishes the Mymetics Corporation 2013 Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the long-term growth and profitability of the Company by (i) providing key people with incentives to improve st |
|
| April 11, 2014 |
- MYMETICS CORPORATION S-8 4-11-2014 Registration No. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MYMETICS CORPORATION (Exact name of registrant as specified in its charter) Delaware 25-1741849 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) c/o Mymetics S.A. Biopole Route de la Corniche, 4 |
|
| March 28, 2014 |
Exhibit 14.1 CODE OF ETHICS The Chief Executive Officer ("CEO") and all senior financial officers, including the Chief Financial Officer and principal accounting officer of Mymetics Corporation (the "Company"), and of any subsidiary that becomes subject to the periodic reporting requirements under Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended, are bound by the p |
|
| March 28, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2013 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 000-25132 MYMETICS CORPORATION (Exact n |
|
| March 28, 2014 |
Exhibit 21.1 SUBSIDIARIES Mymetics Corporation has four subsidiaries: 1. 6543 Luxembourg S.A.(a wholly-owned subsidiary of Mymetics Corporation) is a joint stock company organized under the laws of Luxembourg and does business under the name "6543 Luxembourg S.A." 2. Mymetics S.A. (a wholly-owned subsidiary of Mymetics Corporation) is a company organized under the laws of Switzerland and did busin |
|
| February 28, 2014 |
EXCLUSIVE LICENSE AND COLLABORATION AGREEMENT Exhibit 10.1 *** Text Omitted and Filed Separately Pursuant to a Confidential Treatment Request under 17 C.F.R. §§ 200.80(b)(4) and 240.24b-2(b)(1) EXCLUSIVE LICENSE AND COLLABORATION AGREEMENT This Exclusive License and Collaboration Agreement (this “Agreement”) is entered into as of the 27th day of December, 2013 (the “Effective Date”) by and between RSV Corporation, a corporation organized unde |
|
| February 28, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2014 (December 27, 2013) Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other juris |
|
| January 3, 2014 |
EXCLUSIVE LICENSE AND COLLABORATION AGREEMENT Exhibit 10.1 *** Text Omitted and Filed Separately Pursuant to a Confidential Treatment Request under 17 C.F.R. §§ 200.80(b)(4) and 240.24b-2(b)(1) EXCLUSIVE LICENSE AND COLLABORATION AGREEMENT This Exclusive License and Collaboration Agreement (this “Agreement”) is entered into as of the 27th day of December, 2013 (the “Effective Date”) by and between RSV Corporation, a corporation organized unde |
|
| January 3, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 3, 2014 (December 27, 2013) Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of incorpora |
|
| November 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MYMETICS CORPORA |
|
| August 21, 2013 |
- DEFINITIVE INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: o Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d)(2)) þ Definitive Information Statement MYMETICS CORPORATION (Name of Registrant as Spec |
|
| August 12, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MYMETICS CORPORATION |
|
| August 7, 2013 |
- PRELIMINARY INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: þ Preliminary Information Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d)(2)) ¨ Definitive Information Statement MYMETICS CORPORATION (Name of Registrant as Spec |
|
| July 9, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A Amendment No. 1 x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2012 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 000-25132 MYMETICS CO |
|
| May 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MYMETICS CORPORATION |
|
| April 15, 2013 |
Exhibit 10.1 STRICTLY PRIVATE & CONFIDENTIAL AMENDMENT dated March 28, 2013 to the Share Purchase Agreement dated as of March 5, 2009 and the Amendments thereto dated 19 April 2012, 21 September 2012, 31 October 2012, 1 November 2012, 28 November 2012 and 28 January 2013 between 1. Norwood Immunology Limited ABN 91 095 271 186, of P.O. Box 211, Patterson Lakes, Victoria 3197, Australia (hereinafte |
|
| April 15, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 15, 2013 (March 28, 2013) Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of incorporation |
|
| March 28, 2013 |
EX-14.1 2 ex141.htm EXHIBIT 14.1 Exhibit 14.1 CODE OF ETHICS The Chief Executive Officer ("CEO") and all senior financial officers, including the Chief Financial Officer and principal accounting officer of Mymetics Corporation (the "Company"), and of any subsidiary that becomes subject to the periodic reporting requirements under Section 13(a) or Section 15(d) of the Securities Exchange Act of 193 |
|
| March 28, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2012 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 000-25132 MYMETICS CORPORATION (Exact n |
|
| March 28, 2013 |
Exhibit 21.1 SUBSIDIARIES Mymetics Corporation has four subsidiaries: 1. 6543 Luxembourg S.A.(a wholly-owned subsidiary of Mymetics Corporation) is a joint stock company organized under the laws of Luxembourg and does business under the name "6543 Luxembourg S.A." 2. Mymetics S.A. (a wholly-owned subsidiary of Mymetics Corporation)is a company organized under the laws of Switzerland and did busine |
|
| November 26, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 26, 2012 (November 19, 2012) Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction (Commissio |
|
| November 13, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MYMETICS CORPORA |
|
| September 21, 2012 |
Entry into a Material Definitive Agreement - MYMETICS CORPORATION 8-K 9-18-2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 21, 2012 (September 18, 2012) Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of incor |
|
| August 10, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MYMETICS CORPORATION |
|
| July 6, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MY |
|
| July 2, 2012 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 2, 2012 (June 29, 2012) Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of incorporation) ( |
|
| July 2, 2012 |
Second Amended and Restated Executive Employment Agreement of Dr. Sylvain Fleury. (49) Exhibit 10.1 SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT This Second Amended and Restated Executive Employment Agreement (this “Agreement”) is made as of the 29th day of June 2012 by and between Mymetics Corporation, a Delaware corporation (the “Company”), and Dr. Sylvain Fleury, a natural person, residing in Switzerland (“Executive”) and amends and restates Executive’s Executive Em |
|
| May 11, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MYMETICS CORPORATION |
|
| April 5, 2012 |
Securities and Exchange Commission Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) information to be included in statements filed pursuant to §240.13d-1(a) and amendments thereto filed pursuant to §240.13d -2(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 MYMETICS CORPORATION (Name of Issuer) Common Stock (Title of Class of Securities) 693286 10 6 (CUSIP Number) Oliver Norman Round Enterprises, L |
|
| March 29, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2011 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 000-25132 MYMETICS CORPORATION (Exact n |
|
| March 29, 2012 |
EX-21.1 3 ex211.htm EXHIBIT 21.1 Exhibit 21.1 SUBSIDIARIES Mymetics Corporation has four subsidiaries: 1. 6543 Luxembourg S.A.(a wholly-owned subsidiary of Mymetics Corporation) is ajoint stock company organized under the laws of Luxembourg and does business under the name "6543 Luxembourg S.A." 2. Mymetics S.A. (a wholly-owned subsidiary of Mymetics Corporation)is a companyorganized under the law |
|
| March 29, 2012 |
EX-14.1 2 ex141.htm EXHIBIT 14.1 Exhibit 14.1 CODE OF ETHICS The Chief Executive Officer ("CEO") and all senior financial officers, including the chief financial officer and principal accounting officer of Mymetics Corporation (the "Company"), and of any subsidiary that becomes subject to the periodic reporting requirements under Section 13(a) or Section 15(d) of the Securities Exchange Act of 193 |
|
| March 23, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2012 (March 22, 2012) Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction (Commission (IRS |
|
| February 3, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 3, 2012 (January 30, 2012) Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of incorpora |
|
| November 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MYMETICS CORPORA |
|
| November 14, 2011 |
Exhibit 33 ABBOTT: TERMINATION LETTER Translated Letter from Dutch to English ABBOTT BIOLOGICALS B. |
|
| October 26, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 21, 2011 (October 26, 2011) Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of incorpora |
|
| October 4, 2011 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2011 (May 23, 2011) Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction (Commission (IRS |
|
| October 4, 2011 |
Mymetics reclaims innovative intra-nasal influenza vaccine Exhibit 99.1 Mymetics reclaims innovative intra-nasal influenza vaccine Epalinges, Switzerland, 4 October 2011 ? Mymetics Corporation, a pioneer in the development of vaccines that use the human mucosal system, the body?s first line of defense, to prevent transmission of infectious diseases, announced today that it has been able to regain its innovative intra-nasal influenza vaccine from Solvay. R |
|
| August 15, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MYMETICS CORPORATION |
|
| August 12, 2011 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2011 (August 4, 2011) Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of incorporatio |
|
| May 12, 2011 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MY |
|
| March 28, 2011 |
MYMETICS CORPORATON Route de la Corniche 4 CH-1066 Epalinges, Switzerland July 30, 2010 Exhibit 10.65 MYMETICS CORPORATON Route de la Corniche 4 CH-1066 Epalinges, Switzerland July 30, 2010 Mr. Ernst Luebke 39, Route d?Arzier 1273 Arzier, Switzerland Dear Ernst: This letter is to set forth the agreement between Mymetics Corporation and its subsidiaries (?Mymetics?) and you concerning the termination of your employment with Mymetics (this ?Agreement?). 1. Date of Termination. Your emp |
|
| March 28, 2011 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2010 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 000-25132 MYMETICS CO |
|
| March 28, 2011 |
Exhibit 21.1 SUBSIDIARIES Mymetics Corporation has four subsidiaries: 1. 6543 Luxembourg S.A.(a wholly-owned subsidiary of Mymetics Corporation) is a joint stock company organized under the laws of Luxembourg and does business under the name ?6543 Luxembourg S.A.? 2. Mymetics S.A. (a wholly-owned subsidiary of Mymetics Corporation)is a company organized under the laws of Switzerland and did busine |
|
| March 28, 2011 |
Consulting Agreement dated September 1 2009, between the Company and Mr. Christian Rochet Exhibit 10.64 Consulting Agreement dated September 1 2009, between the Company and Mr. Christian Rochet This Consulting Agreement (the ?Agreement?) dated September 1, 2009, is entered into by and between Mymetics Corporation, a Delaware corporation, with its principal place of business at Route de la Corniche 4, CH-1066 Epalinges, Switzerland (the ?Company?), and Christian J.-F. Rochet, whose prin |
|
| March 28, 2011 |
Exhibit 24.1 POWERS OF ATTORNEY Each person whose signature appears below constitutes and appoints Ernst Luebke as his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any or all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto |
|
| March 28, 2011 |
Exhibit 14.1 CODE OF ETHICS The Chief Executive Officer (?CEO?) and all senior financial officers, including the chief financial officer and principal accounting officer of Mymetics Corporation (the ?Company?), and of any subsidiary that becomes subject to the periodic reporting requirements under Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended, are bound by the p |
|
| March 28, 2011 |
Exhibit 11.1 STATEMENT REGARDING COMPUTATION OF PER SHARE EARNINGS COMPUTATION OF PER SHARE EARNINGS For the Years Ended December 31, 2010, 2009, and 2008 (In Thousands of Euros, Except for Per Share Amounts) BASIC EPS 2010 2009 2008 Net loss per financial statements E (11,428 ) E (10,186 ) E (6,938 ) Weighted average shares outstanding 202,059,230 195,728,698 191,949,969 Basic earnings (loss) per |
|
| March 17, 2011 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment no. 1 ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FIL |
|
| March 16, 2011 |
U.S. Securities and Exchange Commission Exhibit 7.1 U.S. Securities and Exchange Commission 450 Fifth Street, N.W. Washington, DC 20549 RE: Mymetics Corporation We agree with the Company's statements in Item 4.02 of Form 8-K regarding our discovery and immediate reporting of what we believe to be errors in previously issued financial statements. We are in agreement with management's intentions regarding the restatement discussed in this |
|
| March 16, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 16, 2011 (March 9, 2011) Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction (Commission (IRS |
|
| March 7, 2011 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 7, 2011 (March 1, 2011) Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction (Commission (IRS E |
|
| February 22, 2011 |
February 22, 2011 Re: Mymetics Corporation Form 10-K for the Fiscal Year Ended December 31, 2009 Filed April 15, 2010 Form 10-K/A filed January 5, 2011 File NO. |
|
| February 15, 2011 |
MYMETICS LETTERHEAD February 16, 2011 MYMETICS LETTERHEAD February 16, 2011 Via EDGAR Correspondence Jeffrey P. Riedler Assistant Director Division of Corporation Finance U.S. Securities and Exchange Commission Washington, D.C. 20549 Re: Mymetics Corporation Form 10-K for the Fiscal Year Ended December 31, 2009 Filed April 15, 2010 Form 10-K/A filed January 5, 2011 File NO. 000-25132 Dear Mr. Riedler: We have received your February 8, |
|
| January 5, 2011 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A Amendment No. 1 ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2009 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 000 |
|
| January 5, 2011 |
Exhibit 14.1 CODE OF ETHICS The Chief Executive Officer (?CEO?) and all senior financial officers, including the chief financial officer and principal accounting officer of Mymetics Corporation (the ?Company?), and of any subsidiary that becomes subject to the periodic reporting requirements under Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended, are bound by the p |
|
| January 5, 2011 |
Consulting Agreement dated September 1 2009, between the Company and Mr. Christian Rochet Exhibit 10.64 Consulting Agreement dated September 1 2009, between the Company and Mr. Christian Rochet This Consulting Agreement (the ?Agreement?) dated September 1, 2009, is entered into by and between Mymetics Corporation, a Delaware corporation, with its principal place of business at Route de la Corniche 4, CH-1066 Epalinges, Switzerland (the ?Company?), and Christian J.-F. Rochet, whose prin |
|
| January 5, 2011 |
MYMETICS LETTERHEAD January 5, 2011 MYMETICS LETTERHEAD January 5, 2011 VIA EDGAR CORRESPONDENCE Jim B. Rosenberg Senior Assistant Chief Accountant Securities and Exchange Commission Washington, D.C. 20549 Re: Mymetics Corporation Form 10-K for the Fiscal Year Ended December 31, 2009 Filed April 15, 2010 File No. 000-25132 Dear Mr. Rosenberg: We have received your correspondence dated December 10, 2010. We have addressed your commen |
|
| January 5, 2011 |
Exhibit 21.1 SUBSIDIARIES Mymetics Corporation has four subsidiaries: 1. 6543 Luxembourg S.A. (a wholly-owned subsidiary of Mymetics Corporation) is a joint stock company organized under the laws of Luxembourg and does business under the name ?6543 Luxembourg S.A.? 2. Mymetics S.A. (a wholly-owned subsidiary of Mymetics Corporation)is a company organized under the laws of Switzerland and did busin |
|
| December 20, 2010 |
MYMETICS LETTERHEAD December 20, 2010 VIA EDGAR CORRESPONDENCE Jim B. Rosenberg Senior Assistant Chief Accountant Securities and Exchange Commission Washington, D.C. 20549 Re: Mymetics Corporation Form 10-K for the Fiscal Year Ended December 31, 2009 Filed April 15, 2010 File No. 000-25132 Dear Mr. Rosenberg: We have received your correspondence dated December 10, 2010. In accordance with a teleph |
|
| November 12, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MYMETICS CORPORA |
|
| September 13, 2010 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 13, 2010 Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction (Commission (IRS Employer of |
|
| September 13, 2010 |
Mymetics’ novel HIV vaccine to begin new NIH-funded study at University of California, Davis Exhibit 99.1 Press Release: dated September 13 2010 Mymetics? novel HIV vaccine to begin new NIH-funded study at University of California, Davis ? Prof. Christopher J. Miller to lead proof-of-concept study on innovative HIV vaccine aimed at preventing mucosal transmission and infection in macaque monkeys ? Preclinical trial follows previous study where vaccine provided unprecedented 100% protectio |
|
| August 23, 2010 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MYM |
|
| August 16, 2010 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12B-25 NOTIFICATION OF LATE FILING Commission File Number: 000-25132 (Check One): o Form 10-K o Form 20-F o Form 11-K ? Form 10-Q o Form N-SAR o Form N-CSR For Period Ended: June 30, 2010 o Transition Report on Form 10-K and Form 10-KSB o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form N-SAR o Transition Report on Form 10-Q and Form 10-QSB For the Transition Period Ended: Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
|
| August 10, 2010 |
Mymetics Corporation announces new Chief Financial Officer. Exhibit 99.1 MYMETICS DRAFT PRESS RELEASE Mymetics Corporation announces new Chief Financial Officer. EPALINGES, Switzerland, August 6, 2010 ? Mymetics (www.mymetics.com) Corporation (OTCBB: MYMX), announced that Ernest Luebke, Chief Financial Officer, has advised the Board of Directors of his decision to retire as CFO effective July 31st 2010. Mr. Luebke will be succeeded by Mr. Ronald Kempers MS |
|
| August 10, 2010 |
MYMETICS CORPORATON Route de la Corniche 4 CH-1066 Epalinges, Switzerland July 30, 2010 Exhibit 10.1 MYMETICS CORPORATON Route de la Corniche 4 CH-1066 Epalinges, Switzerland July 30, 2010 Mr. Ernst Luebke 39, Route d?Arzier 1273 Arzier, Switzerland Dear Ernst: This letter is to set forth the agreement between Mymetics Corporation and its subsidiaries (?Mymetics?) and you concerning the termination of your employment with Mymetics (this ?Agreement?). 1. Date of Termination. Your empl |
|
| August 10, 2010 |
Exhibit 10.2 CONSULTING AGREEMENT This Consulting Agreement (this ?Agreement?) dated August 1, 2010, is entered into by and between Mymetics Corporation, a Delaware corporation, with its principal place of business at Route de la Corniche 4, CH-1066 Epalinges, Switzerland (the ?Company?), and Ernst Luebke, whose principal address is 39, Route d?Arzier, 1273 Arzier, Switzerland (?Consultant?). 1. C |
|
| August 10, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2010 (August 1, 2010) Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware (State of other jurisdiction of incorporation) 000-25132 (Commiss |
|
| May 17, 2010 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MY |
|
| April 15, 2010 |
Exhibit 14.1 CODE OF ETHICS The Chief Executive Officer (?CEO?) and all senior financial officers, including the chief financial officer and principal accounting officer of Mymetics Corporation (the ?Company?), and of any subsidiary that becomes subject to the periodic reporting requirements under Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended, are bound by the p |
|
| April 15, 2010 |
Exhibit 21.1 SUBSIDIARIES Mymetics Corporation has four subsidiaries: 1. 6543 Luxembourg S.A.(a wholly-owned subsidiary of Mymetics Corporation) is a joint stock company organized under the laws of Luxembourg and does business under the name ?6543 Luxembourg S.A.? 2. Mymetics S.A. (a wholly-owned subsidiary of Mymetics Corporation)is a company organized under the laws of Switzerland and did busine |
|
| April 15, 2010 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2009 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 000-25132 MYMETICS CO |
|
| November 13, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2009 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MYMETICS CORPORA |
|
| August 19, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2009 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MYMETICS CORPORATION |
|
| August 14, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 000-33127 CUSIP Number: (Check one): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: June 30, 2009 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form |
|
| June 25, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 23, 2009 Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction (Commission (IRS Employer of incor |
|
| June 25, 2009 |
Exhibit 99.1 Mymetics Corporation?s Board of Directors announces the Appointment of Jacques-Fran?ois Martin as President and CEO This appointment brings a wealth of experience in the pharmaceutical, biological and life sciences industries to Mymetics as well as adding strength and depth to the company?s management. NYON, Switzerland, June 22, 2009 ? Mymetics (www.mymetics.com) Corporation (OTCBB: |
|
| June 22, 2009 |
Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 22, 2009 (April 1, 2009) Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware (State of other jurisdiction of incorporation) 0 |
|
| June 22, 2009 |
Exhibit 99.2 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF MYMETICS CORPORATION AS OF AND FOR THE THREE MONTHS ENDED MARCH 31, 2009 AND FOR THE YEAR ENDED DECEMBER 31, 2008 The following unaudited pro forma condensed combined balance sheet and unaudited pro forma condensed combined income statements (Unaudited Pro Forma Condensed Combined Financial Information) of Mymetics Corpor |
|
| June 16, 2009 |
FORM 8-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| June 16, 2009 |
Table of Contents Exhibit 99.1 Bestewil Holding B.V. Combined Financial Statements as of and for the years ended December 31, 2008 and 2007 Bestewil Holding B.V. Index Page(s) Report of Independent Auditors 1 Financial Statements Combined Balance Sheets 2 Combined Statements of Operations 3 Combined Statements of Invested Equity 4 Combined Statements of Cash Flows 5 Notes to Combined Financial Sta |
|
| May 15, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2009 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-25132 MYMETICS CORPORATION |
|
| March 12, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 9, 2009 Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware (State of other jurisdiction of incorporation) 000-25132 (Commission File Number) 25 |
|
| March 9, 2009 |
EX-10.1 Exhibit 10.1 ’’’’’’’ SHARE PURCHASE AGREEMENT Dated as of March 5, 2009 relating to the Shares of Bestewil Holding B.V. -1- Table Of Contents 1 Sale and Purchase 6 1.1 Shares 6 1.2 Consideration 6 1.3 Payment of Cash Consideration 10 2 Conditions precedent and Closing Events 10 2.1 Conditions Precedent to Closing 10 2.2 Closing Events 13 3 Representations and Warranties of the Seller 20 3. |
|
| March 9, 2009 |
EX-99.1 3 l35768aexv99w1.htm EX-99.1 Exhibit 99.1 Media Release Mymetics Corporation acquires Virosome Biologicals B.V. This acquisition advances Mymetics’ corporate strategy to expand its vaccine portfolio and enhances Mymetics’ implementation of the virosome delivery technology. NYON, Switzerland, March 9, 2009 — Mymetics (www.mymetics.com) Corporation (OTCBB: MYMX), announced today that it has |
|
| March 9, 2009 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 5, 2009 Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction (Commission (IRS Employer of incor |
|
| February 5, 2009 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2009 Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware (State of other jurisdiction of incorporation) 000-25132 (Commission File Number) |
|
| February 5, 2009 |
Exhibit 10.1 Umbrella Agreement Between: ? On one hand, MYMETICS Corporation (hereinafter MYMETICS), an American de jure corporation with a head office located at 230 Park Avenue, New York 10169, United States of America, represented by its European subsidiary MYMETICS MANAGEMENT, a limited company and Swiss de jure corporation with a head office located at 14, rue de la Colombi?re, Nyon, CH-1260, |
|
| June 30, 2008 |
Unregistered Sales of Equity Securities, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2008 Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware (State of other jurisdiction of incorporation) 000-25132 (Commission File Number) 25 |
|
| May 19, 2008 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2008 Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of incorporation) (Commission File |
|
| May 19, 2008 |
EX-10.1 Exhibit 10.1 FOR IMMEDIATE RELEASE Mymetics Corporation Acquires Preventive Malaria Vaccine From Pevion Biotech AG (Switzerland) Successful Phase I and II Clinical Trials In Switzerland and the UK Results praised by an eminent member of the Pasteur Institute and of the malaria board of the Bill and Melinda Gates Foundation Nyon, Switzerland (May 19, 2008) —Mymetics Corporation (OTCBB: MYMX |
|
| March 10, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1) * MYMETICS CORPORATION (Name of Issuer) Common Stock, $0.01 Par Value (Title of Class of Securities) 693286 10 6 (CUSIP Number) Michael J. Smith Mass Financial Corp. Unit 803, 8th Floor, Dina House, Ruttonjee Centre, 11 Duddell Street, Central, Hong Kon |
|
| March 10, 2008 |
MASS FINANCIAL CORP. Oct. 11, 2007. Societe D’investissements et de gestion financiere (SIGF)SA 36 rue du XXXI decembre 5th Floor CH-1207 Geneva Switzerland This is to confirm that we hereby grant your company an option to purchase the following shares of Mymetics Corporation: 1 million common shares on May 31, 2008 1 million common shares on June 30, 2008 1 million common shares on July 31, 2008 |
|
| February 19, 2008 |
EX-99.1 3 l30222aexv99w1.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE A EUROPEAN HEALTHCARE CONSORTIUM, INCLUDING MYMETICS CORPORATION, AWARDED €7.50 MILLION GRANT Mymetics’ HIV Virosome To Be Used As A Key Platform Nyon, Switzerland (February 14, 2008) — A European healthcare consortium (the “Consortium”) of fifteen members comprised of a publicly founded organization, governmental entities, ac |
|
| February 19, 2008 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 11, 2008 Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware (State of other jurisdiction of incorporation) 000-25132 (Comm |
|
| February 19, 2008 |
EX-10.1 2 l30222aexv10w1.htm EX-10.1 EXHIBIT 10.1 NGIN CONSORTIUM AGREEMENT FINAL VERSION JANUARY 2008 NEXT GENERATION HIV-1 IMMUNOGEN INDUCING BROADLY REACTIVE NEUTRALIZING ANTIBODIES (“NGIN”) Consortium Agreement DISTRIBUTION LIST • European Commission (EC) • Consortium Contractors ABOUT THIS DOCUMENT Purpose The purpose of this document is to amplify the standard contract (“Grant Agreement”) ag |
|
| January 25, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 21, 2008 Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware (State of other jurisdiction of incorporation) 000-25132 (Commission File Number) |
|
| January 14, 2008 |
Co-ownership Agreement dated January 8, 2008 between the Company and INSERM (23) EX-10.2 3 l29546aexv10w2.htm EX-10.2 Exhibit 10.2 [CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH AS BEEN OMITTED HEREIN AND REPLACED WITH A SERIES OF THREE ASTERISKS IN BRACKETS [***], HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.] Co-ownership Agreement (the “Agreement”) Entered into by: INSERM-TRANSFERT S.A., |
|
| January 14, 2008 |
Exploitation Agreement dated January 8, 2008 between the Company and INSERM (23) EX-10.3 Exhibit 10.3 [CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH AS BEEN OMITTED HEREIN AND REPLACED WITH A SERIES OF THREE ASTERISKS IN BRACKETS [***], HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.] Exploitation Agreement (the “Agreement”) Entered into by: INSERM-TRANSFERT S.A., a limited liability company h |
|
| January 14, 2008 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2008 Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of incorporation) (Commission Fi |
|
| January 14, 2008 |
EX-10.1 2 l29546aexv10w1.htm EX-10.1 Exhibit 10.1 [CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH AS BEEN OMITTED HEREIN AND REPLACED WITH A SERIES OF THREE ASTERISKS IN BRACKETS [***], HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.] Co-ownership Agreement (the “Agreement”) Entered into by: INSERM-TRANSFERT S.A., |
|
| October 29, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 23, 2007 Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of incorporation) (Commission F |
|
| October 24, 2007 |
United States Securities and Exchange Commission Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 MYMETICS CORPORATION (Name of Issuer) Common Stock (Title of Class of Securities) 693286 10 6 (CUSIP Number) Sandra Sewell-Jones Round Enterprises Ltd., BVI Sir William Place, St. Peter Port Guernsey, GYI 4HQ Channel Islands Tel. No.: 44 (0) 1481 7 23573 (Name, Address and |
|
| August 3, 2007 |
Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2007 Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of incorporation) (Commission File |
|
| March 30, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ) * MYMETICS CORPORATION (Name of Issuer) Common Stock, $0.01 Par Value (Title of Class of Securities) 693286 10 6 (CUSIP Number) Michael J. Smith Mass Financial Corp. Unit 803, 8th Floor, Dina House, Ruttonjee Centre, 11 Duddell Street, Central, Hong Kong, |
|
| March 30, 2007 |
s - Converted by S, created by BCL Technologies Inc., for SEC Filing |
|
| March 21, 2007 |
Mymetics Resolves Credit Facility and Litigation with MFC Merchant Bank EX-99.1 Exhibit 99.1 Mymetics Resolves Credit Facility and Litigation with MFC Merchant Bank Nyon (Switzerland), March 21, 2007 — Mymetics Corporation (Nasdaq OTC.PK: MYMX.PK) announced today that the Company has agreed to pay 1.49 million euros and to provide 12.5 million Reg S restricted shares to MFC Merchant Bank, SA (MFC) to settle a credit facility originated by MFC in the principal amount o |
|
| March 21, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 19, 2007 Mymetics Corporation (Exact name of registrant as specified in its charter) Delaware 000-25132 25-1741849 (State of other jurisdiction of incorporation) (Commission Fil |
|
| January 17, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 13) * MYMETICS CORPORATION (Name of Issuer) Common Stock, $0.01 Par Value (Title of Class of Securities) 693286 10 6 (CUSIP Number) Michael J. Smith KHD Humboldt Wedag International Ltd. Unit 803, 8/F, Dina House, Ruttonjee Centre, 11 Duddell Street, Centr |
|
| January 17, 2006 |
Sixth Amendment Mymetics Credit Facility, 11.01.2006 Sixth Amendment Mymetics Credit Facility, 11.01.2006 THIS AGREEMENT RELATES TO AN OFFERING OF SECURITIES IN AN OFFSHORE TRANSACTION TO PERSONS WHO ARE NOT U.S. PERSONS (AS DEFINED HEREIN) PURSUANT TO REGULATION S (?REGULATION S?) UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE ?1933 ACT?). NONE OF THE SECURITIES TO WHICH THIS AGREEMENT RELATES HAVE BEEN REGISTERED UNDER THE 1933 AC |
|
| February 17, 2005 |
THIRD AMENDMENT AGREEMENT TO CREDIT FACILITY AGREEMENT THIS THIRD AMENDMENT AGREEMENT is dated for reference the 31st of December 2004, AMONG: MFC MERCHANT BANK S. |
|
| February 17, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 12) * MYMETICS CORPORATION (Name of Issuer) Common Stock, $0.01 Par Value (Title of Class of Securities) 693286 10 6 (CUSIP Number) Michael J. Smith MFC Bancorp Ltd. 8th Floor, Dina House, Ruttonjee Centre, 11 Duddell Street, Central, Hong Kong SAR, China |
|
| February 17, 2005 |
FOURTH AMENDMENT AGREEMENT TO CREDIT FACILITY AGREEMENT WHEREAS: THIS AGREEMENT RELATES TO AN OFFERING OF SECURITIES IN AN OFFSHORE TRANSACTION TO PERSONS WHO ARE NOT U. |
|
| October 25, 2004 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 19, 2004 MYMETICS CORPORATION (Exact name of Registrant as specified in its charter) DELAWARE (State of Incorporation) 000-25132 25-1741849 (Commission File Number) (I.R.S. Emp |
|
| August 8, 2002 |
EX-10.1 4 j9424102exv10w1.txt SHARE EXCHANGE AGREEMENT Exhibit 10.1 SHARE EXCHANGE AGREEMENT This Agreement dated for reference the 30th day of July, 2002. BETWEEN: The undersigned SHAREHOLDERS of Mymetics S.A., more particularly described on the signature pages hereto (collectively, the "SHAREHOLDERS") AND: MYMETICS CORP, a corporation organized under the laws of Delaware in the United States, wi |
|
| May 22, 2002 |
EX-10.6 8 j9424101ex10-6.txt EXHIBIT 10.6 Exhibit 10.6 MYMETICS CORPORATION 50-52 Avenue Du Chanoine Cartellier 69230 Saint-Genis Laval, France July 19, 2001 DIRECTOR AND NON-EMPLOYEE - STOCK OPTION AGREEMENT - (Non-Statutory) Mr. Michael K. Allio 34 Pratt Street Providence, RI 02906 Dear Mr. Allio: I am pleased to advise you that as of the date hereof, the Administrator appointed by the Board of |
